Lexaria Bioscience Corp. 13D/A Filing
Ticker: LEXX · Form: SC 13D/A · Filed: Apr 25, 2024
Sentiment: neutral
Topics: ownership-change, sec-filing, 13d-filing
Related Tickers: LEXX
TL;DR
Lexaria Bioscience Corp. 13D/A filed, shows ownership changes by Boos Wayne W.
AI Summary
On April 25, 2024, Lexaria Bioscience Corp. filed an amendment (No. 2) to its Schedule 13D. This filing relates to the acquisition of common stock by Boos Wayne W. The filing indicates a change in the reporting person's holdings as of March 31, 2024.
Why It Matters
This filing provides updated information on significant beneficial ownership of Lexaria Bioscience Corp. stock, which can influence market perception and trading activity.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant stake changes by large investors, which can lead to increased volatility.
Key Numbers
- 20240425 — Filing Date (Date of the SC 13D/A filing)
- 20240331 — Date of Event (Date of event requiring filing)
Key Players & Entities
- Lexaria Bioscience Corp. (company) — Subject Company
- Boos Wayne W (person) — Filing Person
- Robert B. Goldberg, Esq. (person) — Person Authorized to Receive Notices
FAQ
What is the purpose of this SC 13D/A filing?
This filing is an amendment to a Schedule 13D, indicating a change in the beneficial ownership of Lexaria Bioscience Corp. common stock by the reporting person.
Who is the subject company?
The subject company is Lexaria Bioscience Corp.
Who is the person filing this amendment?
The filing person is identified as Boos Wayne W.
What is the CUSIP number for Lexaria Bioscience Corp. common stock?
The CUSIP number for Lexaria Bioscience Corp. Common Stock, Par Value $0.001 is 52886N.
When was the event that required this filing to occur?
The date of the event which requires filing of this statement is March 31, 2024.
Filing Details
This Form SC 13D/A (Form SC 13D/A) was filed with the SEC on April 25, 2024 by Boos Wayne W regarding Lexaria Bioscience Corp. (LEXX).